Yahoo Web Search

  1. Ads
    related to MERCK & CO., INC
  1. The European Commission granted approvals to Merck MRK and Roche’s RHHBY PD-L1 inhibitors Keytruda and Tecentriq, respectively, and J&J’s JNJ immunology drug Stelara for expanded use.

  2. PDUFA dates are deadlines for the FDA to review new drugs. The FDA is normally given 10 months to review new drugs. If a drug is selected for priority review, the FDA is allotted six months to review the drug.

  3. AbbVie Ends Rova-T Program as 3rd Lung Cancer Study Fails

    Zacks via Yahoo FinanceAug 30 14:21 PM

    AbbVie, Inc. ABBV announced that it is discontinuing development of its small-cell lung cancer (SCLC) candidate rovalpituzumab tesirine or Rova-T after failure of the third study, MERU ...

  4. Top Analyst Reports: Amazon, Merck, PepsiCo & More

    Zacks via Yahoo FinanceSep 03 4:59 AM

    Rapid adoption of Prime driven by customer benefits and strengthening grocery services is aiding the top line. Further, expanding content portfolio is encouraging Prime membership. Further, ...

  5. AstraZeneca's Lupus Drug Meets Primary Endpoint in Study

    Zacks via Yahoo FinanceAug 30 15:16 PM

    AstraZeneca PLC AZN announced positive top-line results from the second phase III study on its human monoclonal antibody anifrolumab, currently under development for treating adult patients ...

  6. AstraZeneca PLC AZN announced that it has secured an approval from China for the label expansion of its marketed drug Tagrisso (osimertinib) for the first-line treatment of adult patients with ...

  7. Forget Pfizer, Add These Big Drugmakers to Your Portfolio

    Zacks via Yahoo FinanceAug 29 13:06 PM

    Pfizer PFE, one of the biggest drugmakers in the world, is witnessing tough times in 2019. Pfizer has a Zacks Rank #5 (Strong Sell). Its earnings estimates have declined 1.7% for 2019 and 11.5% ...

  8. Why Merck (MRK) is a Top Dividend Stock for Your Portfolio

    Zacks via Yahoo FinanceAug 29 13:15 PM

    A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent ...

  9. Par Pharmaceutical, Inc., Endo's operating company, expects to distribute the product through specialty pharmacies beginning this month.

  10. Bristol-Myers Announces Sale of Celgene's Otezla to Amgen

    Zacks via Yahoo FinanceAug 27 12:05 PM

    Bristol-Myers Squibb Company BMY announced that Celgene Corporation CELG has inked an agreement to sell its plaque psoriasis and psoriatic arthritis drug, Otezla, to Amgen AMGN. The deal is ...

  1. Ads
    related to MERCK & CO., INC